Efficient and Rapid Development of Transgenic Hamster Models of TSE's Using a Radical New Technology

Abstract

In the original proposal, we proposed a use of new transposon technology developed by TOSK Inc. to introduce the human, sheep, white tail deer, bovine, and mouse prion genes into golden Syrian hamsters. TOSK Inc. failed to produce a working technology to achieve these goals and therefore we lost a year of research and proposed a new statement of work. This annual report will summarize why we have proposed a revised statement of work and re-state the approved statement of work. With a re-direction of funds and an approved one year no-cost extension, we have proposed to accomplish the following goals: 1) Maintain a scrapie infected sheep flock in Idaho, 2) Use transgenic mice (with the sheep PrP gene) to titer the infectivity of plasma from the sheep flock, 3) Pool, and bring to homogeneity the sheep plasma and separately the frozen whole blood that we have collected over the last five years and redistribute each into aliquots that will serve as a common TSE infected blood reference material, 4) Develop a protocol for distribution of sheep resource materials to academic requesters and a price list for distribution of the same materials to commercial interests, 5)Continue to develop the short incubation time model of sheep scrapie by breeding for VVQQ genotype and infecting with inocula prepared from the first passage transmissions

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2005
Accession Number
ADA446911

Entities

People

  • Irena Alexeeva
  • Marie Bulgin
  • Robert G. Rohwer

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Breeding
  • Contracts
  • Department Of Defense
  • Dilution
  • Diseases And Disorders
  • Education
  • Genes
  • Genetically Modified Organisms
  • Genotypes
  • Governments
  • Incubation
  • Infection
  • Materials
  • Titration
  • Wound Infections

Readers

  • Agent-Based Social Robotics and Mobile-Assisted Learning in Virtual Environments.
  • Clinical Trial Research.
  • Trauma Surgery or Emergency Medicine.